Radiolabeled Angiopep‐2 Peptide Vector as a Preclinical Platform for Blood–Brain Barrier Targeting: Synthesis, Radiolabeling, and Preliminary In Vivo Biodistribution in Mice
Journal of Peptide Science · 2026-07 · 32 (7)
DOI: 10.1002/psc.70109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Peptide Science, online erschienen am 10.06.2026. Verfasst von Evgenia Fotou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Section of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, Ioannina, Greece. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Peptides, Radiopharmaceuticals, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-NextGenerationEU.
Abstract (Originalsprache)
Brain tumor therapy remains limited by the blood–brain barrier (BBB), which restricts drug access. BBB‐penetrating peptides offer a promising strategy for delivering therapeutic and diagnostic payloads. Angiopep‐2 is a well‐established vector, yet novel radioconjugates based on this vector remain of interest. We report the synthesis and evaluation of DOTA‐Angiopep‐2 for radiolabeling with Lutetium‐177 ( 177 Lu) and Terbium‐161 ( 161 Tb). Notably, 177 Lu serves as a β‐ and γ‐emitter, whereas 161 Tb is an Auger and β‐emitter; both are utilized in therapy and SPECT imaging. Peptides were synthesized via solid‐phase peptide synthesis. Cytotoxicity assays in T98 glioblastoma cells showed that Angiopep‐2 is well‐tolerated, maintaining ~100% viability at 20 μM and a moderate decline up to 100 μM. Radiolabeling achieved yields > 95% with excellent radiochemical stability at room temperature for up to 10 days and moderate stability in the presence of human serum. Biodistribution in healthy CFW mice showed a brain‐associated radioactivity of 0.24% ± 0.05% IA/g at 5 min p.i. and a 12‐fold increase in the brain‐to‐blood ratio (0.028–0.339) by 60 min p.i. These results support DOTA‐Angiopep‐2 as a versatile platform for radionuclide delivery and a potential candidate for future glioma‐targeted studies. Further studies in tumor‐bearing models are ongoing to evaluate therapeutic efficacy and translational potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, Ioannina, Greece.
- Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center for Scientific Research "Demokritos", Athens, Greece.
- Neurosurgical Institute, University of Ioannina, Ioannina, Greece.
ORCID-Profile: Vassilios Tsikaris, Penelope Bouziotis, Andreas G Tzakos
Förderung
- European Union-NextGenerationEU
Zitieren
APA
Fotou, E., Apostolopoulou, A., Bika, C. G., Giannakopoulou, M., Bajwa, D. E., Moussis, V., Tsikaris, V., Gerothanassis, I. P., Alexiou, G. A., Bouziotis, P., & Tzakos, A. G. (2026). Radiolabeled Angiopep‐2 Peptide Vector as a Preclinical Platform for Blood–Brain Barrier Targeting: Synthesis, Radiolabeling, and Preliminary In Vivo Biodistribution in Mice. Journal of Peptide Science, 32(7). https://doi.org/10.1002/psc.70109
Vancouver
Fotou E, Apostolopoulou A, Bika CG, Giannakopoulou M, Bajwa DE, Moussis V, et al. Radiolabeled Angiopep‐2 Peptide Vector as a Preclinical Platform for Blood–Brain Barrier Targeting: Synthesis, Radiolabeling, and Preliminary In Vivo Biodistribution in Mice. Journal of Peptide Science. 2026;32(7). doi:10.1002/psc.70109
BibTeX
@article{Fotou2026,
author = {Fotou, Evgenia and Apostolopoulou, Adamantia and Bika, Christina-Georgia and Giannakopoulou, Maria and Bajwa, Danai-Efraimia and Moussis, Vassilios and Tsikaris, Vassilios and Gerothanassis, Ioannis P and Alexiou, George A and Bouziotis, Penelope and Tzakos, Andreas G},
title = {Radiolabeled Angiopep‐2 Peptide Vector as a Preclinical Platform for Blood–Brain Barrier Targeting: Synthesis, Radiolabeling, and Preliminary In Vivo Biodistribution in Mice},
journal = {Journal of Peptide Science},
year = {2026},
volume = {32},
number = {7},
doi = {10.1002/psc.70109}
}
EUVIMED